Aggregation rate - Globe Thesis

Keyword [Aggregation rate] Result: 61 - 80 \| Page: 4 of 5
61.	Analysis On The Effectiveness Of Ticagerlor In Patients With Acute Coronary Syndrome
62.	Correlation Between Platelet Function Test And Dual Antiplatelet Therapy In Patients With Non-ST-segment Elevation Acute Coronary Syndrome
63.	The Efficacy And Safety Of Ticagrelor Reduction Under The Guidance Of Platelet Aggregation Rate
64.	The Retrospective Analysis Of The Related Influencing Factors On Platelet Aggregation Rate
65.	Changes And Clinical Significance Of Platelet Aggregation Rate,Plasma Fibrinogen And D-dimer In Pregnant Women With Gestational Diabetes Mellitus
66.	Comparison Of Short-term Efficacy And Safety Of Different Doses Of Clopidogrel On Antiplatelet Effect In Light Acute Cerebral Infarction
67.	Loading Dose Clopidogrel Improves The Prognosis Of Minor Stroke Or Transient Ischemic Attack Patients By Decreasing Maximum Aggregationratio Of CYP2C19*2 Carriers
68.	Comparison Of The Efficacy Of The Ticagrelor And Clopidogrel After The Direct PCI In Patients With Acute St-segment Elevation Myocardial Infarction
69.	Analysis Of CYP2C19 Gene Polymorphism In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
70.	Effects Of Atorvastatin On Chloropidogrel Pharmacodynamics And Pharmacokinetics And Clinical Drug Analysis
71.	Relation Between Platelet Aggregation Rate And Recent Major Adverse Cardiovascular Events In Patients With Acute Coronary Syndrome
72.	A Comparative Study Of Clopidogrel-Hydrogen Reduction And Direct Deactivation After Intracoronary DES Implantation After 12 Months
73.	Clinical Efficacy Of Tirofiban Injection In Patients With Progressive Stroke
74.	Antiplatelet Efficacy Of P2Y12 Receptor Antagonists In Patients With Different CYP2C19 Genotypes
75.	Thrombelastogram Combined With Platelet Aggregation Rate Test Was Used To Evaluate The Efficacy And Safety Of Antiplatelet Therapy In Patients With Coronary Slow Flow
76.	Evaluation Of Efficacy And Safety Of Thromboelastography Combined With Platelet Aggregation Rate In Patients After PCI
77.	The Guiding Role Of PEAR1 Gene Detection In Double Antiplatelet Therapy
78.	Change Of Platelet Aggregation Rate,D-D And Uterine Arterial Blood Flow In Patients With Rsa And Observation The Effect Of Heparin Treatment
79.	Analysis The Effect Of Gene And Platelet Testing Guide Dual Anti-upgrade Therapy After PCI In Patients With ACS
80.	Correlation Between Clopidogrel Resistance And CYP2C19 Gene Polymorphism In Patients After Emergency PCI
<<First <Prev Next> Last>> Jump to